Verification evidence is still being completed.
PDF / print export
TissUse
Berlin, Germany
- Verified lead
- Uwe Marx
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Chief Executive Officer
- 2026 technical specialization
- Organ-on-Chip, Microphysiological Systems, Drug Development Models, Toxicology, and Research Platforms
- Review cycle
- May 2026
- Full address
- Oudenarder Strasse 16, 13347 Berlin, Germany
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official TissUse contact page confirming the Berlin address.
- Editorial note
- TissUse is published because official company materials confirm current leadership, Berlin operating address, and a real organ-on-chip and microphysiological-systems platform.
Organ-on-Chip, Microphysiological Systems, Drug Development Models, Toxicology, and Research Platforms
Official leadership disclosure, Official Berlin address disclosure, Research-platform claim
TissUse is published because official company materials confirm current leadership, Berlin operating address, and a real organ-on-chip and microphysiological-systems platform.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
TissUse runs organ-on-chip development, microphysiological systems engineering, and drug testing and toxicology modeling in Berlin, Germany.
- Lead
- Uwe Marx (verified ↗)
- Address
- Oudenarder Strasse 16, 13347 Berlin, Germany (source ↗)
- Compliance
- Not yet on record
- Last reviewed
- 22 Mar 2026 (2mo ago)
- Scale
- Research-platform operations
- Capabilities
- Organ-on-Chip Development · Microphysiological Systems Engineering · Drug Testing and Toxicology Modeling
- Founded
- 2010
- Headcount
- 11-50
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED MARCH 2026
Uwe Marx
Chief Executive Officer
Full addressOudenarder Strasse 16, 13347 Berlin, Germany
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source
Official TissUse certificate and company materials listing the Berlin address.
Open sourceResearch-platform operations
Berlin, Germany. Organ-on-Chip, Microphysiological Systems, Drug Development Models, Toxicology, and Research Platforms. Review completed on 22 Mar 2026.
German corporate and research-platform oversight
Official leadership disclosure, Official Berlin address disclosure, Research-platform claim
Organ-on-Chip, Microphysiological Systems, Drug Development Models, Toxicology, and Research Platforms
TissUse is published because official company materials confirm current leadership, Berlin operating address, and a real organ-on-chip and microphysiological-systems platform.
Editorial note
TissUse is published because official company materials confirm current leadership, Berlin operating address, and a real organ-on-chip and microphysiological-systems platform.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Organ-on-Chip Development
Microphysiological Systems Engineering
Drug Testing and Toxicology Modeling
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Microphysiological systems workflow
Organ-chip engineering systems
Platform R&D infrastructure
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
22 Mar 2026: Executive identity confirmed via official management disclosure.
22 Mar 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is TissUse located?
- TissUse operates from Oudenarder Strasse 16, 13347 Berlin, Germany, Berlin, Germany.
- Who runs TissUse?
- TissUse is led by Uwe Marx, Chief Executive Officer. Verified 22 Mar 2026.
- What does TissUse do?
- TissUse runs organ-on-chip development, microphysiological systems engineering, and drug testing and toxicology modeling in Berlin, Germany. Core capabilities: Organ-on-Chip Development, Microphysiological Systems Engineering, Drug Testing and Toxicology Modeling.
Editorial context
Related technical briefs
Briefs that name Berlin as a covered market or city.